Close

UPDATE: RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform Mar 21, 2022 04:56AM
ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference May 6, 2020 04:30PM
Immunogen Inc. (IMGN) PT Lowered to $4 at RBC Capital Aug 5, 2019 06:51AM
Immunogen Inc. (IMGN) PT Lowered to $5 at RBC Capital Jun 28, 2019 06:04AM
Immunogen Inc. (IMGN) PT Lowered to $6 at RBC Capital; Remains Positive Mar 4, 2019 06:49AM


Feb 8, 2018 09:25AM RBC Capital Assumes Immunogen Inc. (IMGN) at Outperform
Feb 6, 2018 04:30PM ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
Jan 31, 2018 09:24AM Pre-Open Movers 01/31: (CASC) (SFLY) (KNX) Higher; (BLCM) (MGI) (CACC) Lower (more...)
Oct 11, 2017 04:01PM ImmunoGen Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 6, 2017 05:38AM Immunogen (IMGN) Prices 14.5M Share Common Offering at $6.50/Sh
Oct 5, 2017 08:30PM ImmunoGen Announces Pricing of Public Offering of Common Stock
Oct 4, 2017 04:02PM Immunogen (IMGN) Announces 13M Share Common Offering
Oct 4, 2017 04:01PM ImmunoGen Announces Proposed Public Offering of Common Stock
Jul 6, 2017 09:30AM Pre-Open Movers 07/06: (HSNI) (BGNE) (CYTX) Higher; (EGLT) (TAHO) (AZZ) Lower (more...)
Jul 6, 2017 07:26AM UPDATE: RBC Capital Upgrades Immunogen Inc. (IMGN) to Outperform; Sees Another 64% Upside
Feb 2, 2017 05:00PM ImmunoGen Announces Webcasts of Presentations at Upcoming Investor Conferences
May 2, 2016 02:20PM Notable 52-Week Highs and Lows 5/2: (SYY) (MITK) (YNDX) High; (STX) (IMGN) (HAE) Low
May 2, 2016 10:52AM RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform
Apr 29, 2016 02:44PM UPDATE: RBC Capital Cuts Immunogen Inc. (IMGN) to 'Sector Perform' on Concerns About Lead Asset
Feb 3, 2016 08:00AM ImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor Conferences
Nov 16, 2015 01:34PM Buy Immunogen (IMGN) on Clovis-Related Sell-Off, RBC Capital Says
Sep 18, 2015 03:24PM ImmunoGen (IMGN) Reveals Mirvetuximab Phase II Design at Investor Day; RBC Affirms at 'Outperform'
Jul 27, 2015 12:41PM Immunogen (IMGN) PT Raised to $20 at RBC Capital Following Meetings
Mar 23, 2015 03:03PM Takeda Deal an Endorsement of Immunogen's (IMGN) ADC technology, RBC Capital Says
Jan 30, 2015 09:30AM Pre-Open Stock Movers 1/30: (BAMM) (ICPT) (AMZN) Higher; (GENE) (DECK) (ALGN) Lower (more...)
Sep 30, 2013 10:24AM Notable Analyst Rating Changes 09/30: (BBRY) (CIT) (CMG) Upgraded; (IP) (ICI) (ARIA) Downgraded
Aug 22, 2012 10:48AM Notable Analyst Rating Changes 08/22: (CSIQ) (CNP) (CX) Upgraded; (CLWR) (TSL) (FGP) Downgraded
May 31, 2011 10:35AM Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
Apr 8, 2011 07:49AM RBC Capital Upgrades Immunogen Inc. (IMGN) to Outperform
Aug 27, 2010 11:13AM RBC Capital Downgrades Immunogen (IMGN) to Sector Perform
May 10, 2010 11:18AM ImmunoGen (IMGN) Says Underwriters Exercised Over-Allotment Option: Total Offer for 10.35M Shares